"Don't miss out on China!" and "What are you doing about China?" Catch phrases like these are spreading among managers all over the world. Just take a brief look at the business class occupancy of flights from Europe, North America or Japan to major Chinese cities: This gives you a glimpse of how business people are attracted by steady growth rates of 6 percent to 10 percent. It also indicates how much attention is given to a market featuring 1.3 billion potential consumers and a government committed to rapidly changing the country from an agricultu- dominated developing country into one of…mehr
"Don't miss out on China!" and "What are you doing about China?" Catch phrases like these are spreading among managers all over the world. Just take a brief look at the business class occupancy of flights from Europe, North America or Japan to major Chinese cities: This gives you a glimpse of how business people are attracted by steady growth rates of 6 percent to 10 percent. It also indicates how much attention is given to a market featuring 1.3 billion potential consumers and a government committed to rapidly changing the country from an agricultu- dominated developing country into one of the world's economic powerhouses. Most of the global industrial players have had economic ties with China for decades already, but they were further strengthened after the country's opening to the world in the early 1980s. Furthermore, China's accession to the World Trade Or- nization is expected to catapult this already surging economy into another sphere of development.
At detailed look at China s increasingly important chemical and pharmaceutical industry. One central aspect is the political and economic situation in China with its strategic and operational implications for Western chemical and pharma companies. Numerous case examples describe how Western companies, such as BASF, Bayer, Bicoll, Ciba, Degussa, DSM and Novartis are managing their market entry in China. The book also analyzes the threat of Western companies in their home markets by Chinese competitors.
Inhaltsangabe
The Chemical Industry in China.- The Global Chemical Industry.- The Petrochemical Industry in China.- Activities of European Chemical Companies in China.- Research and Development in China.- Chemical Industry Parks in China.- Trends in the Chinese Fine Chemicals Market - Opportunities and Threats for the European Fine Chemicals Industry.- Chemicals for China's Chip Industry.- The Pharmaceutical Industry in China.- China's Pharmaceutical Market: Business Environment and Market Dynamics.- Developing the Pharmaceutical Business in China - The Case of Novartis.- China's Approach to Innovative Pharmaceutical R&D: A Review.- Foreign Direct Investment by Multinational Corporations in China - The Pharmaceutical Sector.- Competing in the Chinese Antibiotics Market - Cephalosporins 1982-2000.- The Experience of Successful European Companies in China.- Swimming Ahead of the Shoal - The History of BASF in Greater China.- Establishing a Competitive Production Network in Asia.- Bayer - A Multinational Committed to China.- Bicoll - The First Sino-German Biotechnology Company.- Ciba Specialty Chemicals in China - Global Direction and Local Expertise.- Degussa: Transforming the China Region.- A Toolbox for China - Lessons from the China Experience of Degussa Construction Chemicals.- DSM in China: In Touch with Evolving Needs in the Specialty Chemicals Market.- Vitamins - Opportunities and Challenges for Both Western and Chinese Producers.
The Chemical Industry in China.- The Global Chemical Industry.- The Petrochemical Industry in China.- Activities of European Chemical Companies in China.- Research and Development in China.- Chemical Industry Parks in China.- Trends in the Chinese Fine Chemicals Market - Opportunities and Threats for the European Fine Chemicals Industry.- Chemicals for China's Chip Industry.- The Pharmaceutical Industry in China.- China's Pharmaceutical Market: Business Environment and Market Dynamics.- Developing the Pharmaceutical Business in China - The Case of Novartis.- China's Approach to Innovative Pharmaceutical R&D: A Review.- Foreign Direct Investment by Multinational Corporations in China - The Pharmaceutical Sector.- Competing in the Chinese Antibiotics Market - Cephalosporins 1982-2000.- The Experience of Successful European Companies in China.- Swimming Ahead of the Shoal - The History of BASF in Greater China.- Establishing a Competitive Production Network in Asia.- Bayer - A Multinational Committed to China.- Bicoll - The First Sino-German Biotechnology Company.- Ciba Specialty Chemicals in China - Global Direction and Local Expertise.- Degussa: Transforming the China Region.- A Toolbox for China - Lessons from the China Experience of Degussa Construction Chemicals.- DSM in China: In Touch with Evolving Needs in the Specialty Chemicals Market.- Vitamins - Opportunities and Challenges for Both Western and Chinese Producers.
Rezensionen
From the reviews: "China, with its potential market of 1.3 billion consumers, has resurrected the western world's stagnant economic outlook. ... This is an interesting book on the global chemical industry and the business practices of multinational companies." (Helmut Hügel, Chemistry in Australia, December, 2005)
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826